sk&f 82958 has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cory-Slechta, DA; McCoy, L; Richfield, EK | 1 |
1 other study(ies) available for sk&f 82958 and 6-cyano-7-nitroquinoxaline-2,3-dione
| Article | Year |
|---|---|
Regional decreases in alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) and 6-[3H]cyano-7-nitroquinoxaline-2,3-dione ([3H]CNQX) binding in response to chronic low-level lead exposure: reversal versus potentiation by chronic dopamine
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzazepines; Binding Sites; Brain; Dopamine Agonists; Lead; Male; Osmolar Concentration; Rats; Rats, Inbred Strains; Reference Values; Time Factors; Tissue Distribution; Tritium | 1997 |